Checkpoint Inhibitors in Malignant Pleural Mesothelioma
0 Просмотры
• 07/02/23
0
0
встраивать
administrator
Подписчики
Mark Socinski, MD; Mary Jo Fidler, MD; Roy Herbst, MD, PhD; Geoffrey Oxnard, MD; and Naiyer Rizvi, MD discuss the potential for checkpoint inhibitors, such as pembrolizumab, for malignant mesothelioma. Also discussed is the importance of trials that can be done in the community setting.
Показать больше
Комментарии Facebook
SORT BY-
Лучшие комментарии
-
Последние комментарии